Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01713816 · ClinicalTrials.gov registry record
Human Brain Antioxidants During Oxidative Stress
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 52
- Enrollment target
NCT01713816: Completed study, sponsored by University of Minnesota.
NCT01713816 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01713816 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
Antioxidants are important for having a good memory and for smart thinking when people get old, and that is important for everyone's quality of life. This research will find out if normal aging and Alzheimer's disease use up brain antioxidants. It will develop a new imaging tool that can help doctors to stop cognitive decline.
Primary Outcome
Occipital cortex and posterior cingulate ascorbate and glutathione concentration in young and elder patients as well as in patients with AD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-07-24 |
What the finished NCT01713816 record still lists
NCT01713816 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01713816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01713816 about?
NCT01713816 is a clinical study titled "Human Brain Antioxidants During Oxidative Stress". Antioxidants are important for having a good memory and for smart thinking when people get old, and that is important for everyone's quality of life. This research will find out if normal aging and Alzheimer's disease use up brain antioxidants. It will develop a new imaging tool that can help doctor...
What is the current status of trial NCT01713816?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2013-06. Estimated completion is 2018-07-24.
Who is sponsoring clinical trial NCT01713816?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia